Clinical Trials Browser

Completed × Astrocytoma × poly ICLC × Clear all

NCT00795457 2019-08-30

Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Phase EARLY_PHASE1 Completed

Astrocytoma, Glioma

NCT00058123 2018-08-21

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Phase 2 Completed

55 enrolled 8 charts

Astrocytoma, Brain Neoplasms, Ependymoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00874861 2015-12-08

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Phase EARLY_PHASE1 Completed

Astrocytoma, Neoplasms, Oligodendroglioma